MeSH term | MeSH ID | Detail |
---|---|---|
Adenocarcinoma | D000230 | 166 associated lipids |
Acidosis | D000138 | 13 associated lipids |
Abortion, Habitual | D000026 | 5 associated lipids |
Thromboxane b2 is a lipid of Fatty Acyls (FA) class. Thromboxane b2 is associated with abnormalities such as endothelial dysfunction, Diabetes Mellitus, Non-Insulin-Dependent, Diabetes Mellitus, Ischemia and Thrombocytosis. The involved functions are known as Platelet Activation, Excretory function, Anabolism, Inflammation and mRNA Expression. Thromboxane b2 often locates in Endothelium, Hepatic and Microsomes, Liver. The associated genes with Thromboxane b2 are PTGS2 gene, prothrombin fragment 2 and CCL14 wt Allele.
To understand associated biological information of Thromboxane b2, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.
Thromboxane b2 is suspected in endothelial dysfunction, Diabetes Mellitus, Non-Insulin-Dependent, Diabetes Mellitus, Ischemia, Thrombocytosis, Acute Coronary Syndrome and other diseases in descending order of the highest number of associated sentences.
Disease | Cross reference | Weighted score | Related literature |
---|
We collected disease MeSH terms mapped to the references associated with Thromboxane b2
There are no associated biomedical information in the current reference collection.
Associated locations are in red color. Not associated locations are in black.
Location | Cross reference | Weighted score | Related literatures |
---|
Function | Cross reference | Weighted score | Related literatures |
---|
There are no associated biomedical information in the current reference collection.
Gene | Cross reference | Weighted score | Related literatures |
---|
There are no associated biomedical information in the current reference collection.
Authors | Title | Published | Journal | PubMed Link |
---|---|---|---|---|
Wang H | [Alteration of thromboxane A2/prostacyclin and their effect on spinal cord blood flow in experimental spinal cord injury in rats]. | 1993 | Zhonghua Wai Ke Za Zhi | pmid:8033727 |
Zhou YG et al. | [Protective effect of PGI2 on experimental ARDS and factors influencing it]. | 1987 | Zhonghua Wai Ke Za Zhi | pmid:3330705 |
Mao E et al. | [Pancreatic ischemia: a continuous injury factor in acute necrotic pancreatitis]. | 1997 | Zhonghua Wai Ke Za Zhi | pmid:10374521 |
Xing X et al. | [Preserving remnant liver function after major hepatic vein occlusion]. | 1998 | Zhonghua Wai Ke Za Zhi | pmid:11825430 |
Xing X and Xia S | [The injury of liver sinusoidal endothelial cells in a rat's isolated liver perfusion (ILP) model for regional chemotherapy]. | 1996 | Zhonghua Wai Ke Za Zhi | pmid:9275689 |
Xiao J et al. | [Effects of platelet activating factor and platelet activating factor receptor antagonist on spinal cord blood flow after spinal cord injury]. | 1995 | Zhonghua Wai Ke Za Zhi | pmid:8762548 |
Wang ZG et al. | [Experimental study and clinical application of endothelium seeded vena caval prostheses]. | 1994 | Zhonghua Wai Ke Za Zhi | pmid:7842898 |
Yu HZ | [Determinations of CSF and plasma concentrations of thromboxane B2 and 6-keto-PGF1 alpha in stroke patients]. | 1988 | Zhonghua Shen Jing Jing Shen Ke Za Zhi | pmid:3402273 |
Gao XG | [Plasma concentrations of thromboxane B2 and 6-keto-PGF1 alpha in patients with cerebral hemorrhage]. | 1988 | Zhonghua Shen Jing Jing Shen Ke Za Zhi | pmid:3402274 |
Jiang K | [The study of occurrence mechanism in acute and chronic cerebral vasospasm]. | 1992 | Zhonghua Shen Jing Jing Shen Ke Za Zhi | pmid:1304997 |
Cao QL | [Dynamic analysis of plasma TXB2 determined by radioimmunoassay in 30 cases of cerebral infarction]. | 1986 | Zhonghua Shen Jing Jing Shen Ke Za Zhi | pmid:3743234 |
Xie P | [Clinical significance of TXB2 level in CSF of patients with acute cerebrovascular diseases]. | 1986 | Zhonghua Shen Jing Jing Shen Ke Za Zhi | pmid:3743244 |
Zhao J | [Treatment of acute cerebral infarction with PGI2--evaluating the clinical effect and observation of dynamic changes in plasma TXB2 and 6-keto PGF1 alpha levels]. | 1991 | Zhonghua Shen Jing Jing Shen Ke Za Zhi | pmid:1889319 |
Teng Y | [The effect of hyperbaric oxygenation on prostaglandin I2 and thromboxane A2 during reperfusion for experimental cerebral ischemia in rabbits]. | 1992 | Zhonghua Shen Jing Jing Shen Ke Za Zhi | pmid:1591957 |
Wang DP et al. | [Effect of the leech on 6-keto-PGF1 alpha, TXB2, total cholesterol and triglycerides in experimental hyperlipemic rabbits]. | 1988 | Zhonghua Nei Ke Za Zhi | pmid:3219953 |
Sun B et al. | [The experimental observation on the procedure of atherosclerotic restenosis following PTCA]. | 1995 | Zhonghua Nei Ke Za Zhi | pmid:8697911 |
Liu H et al. | [Effects of low dose aspirin on platelet function and prostaglandins metabolism in systemic and coronary circulation in patients with ischemia heart disease]. | 1995 | Zhonghua Nei Ke Za Zhi | pmid:8697924 |
Shen XY et al. | [Changes in circulatory thromboxane B2 and 6-keto-prostaglandin F1 alpha in acute myocardial infarction]. | 1987 | Zhonghua Nei Ke Za Zhi | pmid:3652838 |
Pan YZ et al. | [The clinical significance of platelet activation during exercise-induced myocardial ischemia]. | 1994 | Zhonghua Nei Ke Za Zhi | pmid:7520851 |
Zheng L et al. | [Changes of thromboxane A2 (TXA2) and prostacyclin (PGI2) in COPD patients with pulmonary hypertension]. | 1991 | Zhonghua Nei Ke Za Zhi | pmid:1864178 |